| Literature DB >> 29108585 |
Fakhar Singhera1, Emily Cooper1, Louis Scampavia2, Timothy Spicer1.
Abstract
Biomedical translational research has relied on two dimensional (2D) cell cultures for drug discovery over the decades, requiring cells to grow on a flat surface which does not always accurately model in vivo biological states. Three dimensional (3D) cell cultures, also known as 3D spheroids or organoids, grow as cellular tissues that are more physiologically relevant especially with respect to emulating cancer tumor-like structures [1]. While attractive, current methods for generating 3D spheroids has yet to replace 2D culturing methods used for drug discovery efforts that employ high-throughput screening (HTS), having limitations with scalability, reproducibility, and compatibility predominantly associated with conventional microtiter plate usage. Presented is a novel use of bead injection for the reproducible placement of spheroids and beads into high density microtiter plates of a 384- and 1536- well format.Entities:
Keywords: 3D cell culture; Bead injection; Cancer; Microfluidics; Microtiter plate; Organoid; Spheroid
Year: 2017 PMID: 29108585 PMCID: PMC5683093 DOI: 10.1016/j.talanta.2017.09.022
Source DB: PubMed Journal: Talanta ISSN: 0039-9140 Impact factor: 6.057